[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-370748-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-370748-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","the-presence-of-non-exhausted-senescent-t-cells-in-breast-cancer-patients","The Presence of Non-Exhausted Senescent T Cells in Breast Cancer Patients","","This research investigates cancer-associated senescent T cells in breast cancer patients and evaluates how age progression shapes their senescent phenotypes. Exhausted T-cell subsets were identified by excluding PD1+ exhausted lineages, while CD28- cells defined senescence, and CD57 expression further refined phenotypes. Flow cytometry was performed on a CytoFLEX system and analyzed with CytExpert. Both senescent and non-exhausted senescent T cells increased, with age-linked rises in CD28-CD57+ cells and an attenuation of dominant CD28-CD57− cells after age 52, suggesting non-exhausted senescence as a potential immune dysfunction concern in young and elderly patients.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-presence-of-non-exhausted-senescent-t-cells-in-breast-cancer-patients/370748/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-presence-of-non-exhausted-senescent-t-cells-in-breast-cancer-patients/370748.png","ImageObject",300,407,{"name":42,"@type":43},"Pentious","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-24","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main objective of the study?","Question",{"text":63,"@type":64},"To determine whether cancer-associated non-exhausted senescent T cells are present in breast cancer patients and to assess how age progression affects their senescent phenotypes.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were exhausted and senescent T cells distinguished?",{"text":68,"@type":64},"Exhausted T-cell lineages were excluded using the PD1 marker, while senescent phenotypes were determined using CD28- and further characterized with CD57 expression.",{"name":70,"@type":61,"acceptedAnswer":71},"What did the results show about non-exhausted senescent T cells and age?",{"text":72,"@type":64},"Both senescent and non-exhausted senescent T cells increased in breast cancer patients; CD28-CD57+ cells rose with age progression, and dominant CD28-CD57- cells were attenuated after 52 years of age.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},370748,1790314946,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":112,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":118,"preview_page_count":33,"preview_urls":145},1374404730887,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","RESEARCH ARTICLE  \nEditorial Process: Submission:09/28/2024 Acceptance:05/09/2025  \nThe Presence of Non-Exhausted Senescent T Cells in Breast Cancer Patients  \nSikritDenariyakoon1*, Athina Giannoudis2, Charoenchai Puttipanyalears3, Kris Chatamra1, Apiwat Mutirangura3  \nAbstract  \nObjective: This study aimed to investigate the presence of cancer-associated senescent T cells in breast cancer patients and the impact of the progression of age on their senescent phenotypes. Methods: The exhausted T cell lineage was excluded from the analysis ofT cells by using PD1 marker. The percentages of CD28-cells were used to determine the senescent phenotype, in which the CD57 expression was used to further characterize their phenotypes. The flow cytometry was used on CytoFLEX flow cytometer and analysed with CytExpert analysis software. Results: In this study, both senescent and non-exhausted senescent T cells were significantly increased in breast cancer patients. However, non-exhausted T cells could demonstrate more significant proportion ofsenescent T cells, and these phenotypes in CD8+ T cells were increased in breast cancer patients, which were 53.03% and 37.25%(p\u003C0.001) . Moreover, CD28-CD57-cells of non-exhausted CD8+ T cells were increased irrespective of age, while the increase in CD28-CD57+ cells was positively correlated with the progression of age (r=0.353, p=0.015) . In addition, the predominant CD28-CD57-cells were attenuated after 52 years of age. Conclusion: The presence of non-exhausted senescent T cells seemed to be a concern regarding immune dysfunction in breast cancer patients. These phenotypes were presented in both young-age and old-age breast cancer, but the terminal phenotype seemed to be abundant in the elderly.  \nKeywords: T cell senescence-breast cancer-CD28-T cell  \nAsian Pac J Cancer Prev, 26 (5), 1633-1640  \nIntroduction  \nThe impairment of T cell responses is widely recognized in promoting carcinogenesis according to the aberration of immune-surveillance and inadequate immune responses [1, 2]. The T cell dysfunctions, such as T cell anergy, exhaustion and senescence, are the important mechanisms of this failure [3, 4] . The senescent T cells are terminally differentiated T cells, which are pronounced in the elderly, and also found as dysfunctional T cells in many cancers [5]. However, the senescent T cells seem tobe intertwined with exhausted T cells in many previous studies [3, 6, 7] . Recently, exhausted T cells have been found to demonstrate different pathogenesis, in which chronic antigen stimulation is the main mechanism [6, 8], and these T cells express immune checkpoint molecules [9]. The senescent T cells enrich of DNA damage levels, and express the senescent phenotypes [10] . In previous in-vitro studies, peripheral T cells became senescent after being co-cultured with various types of cancer cell-lines or tumour-derived suppressive immune cells, and these  \nsenescent T cells showed an increased in DNA damage markers [11-13]. These entities ofT cells are distinctive in terms of phenotypes and pathogenesis in cancer, therefore, the differentiation of these two entities in cancer patients would point out the significance of senescent T cells in breast cancer patients.  \nThe presence ofsenescent T cells has been demonstrated in patients with various types of cancer [5]. Furthermore, the presence of these cells has been linked with poorer prognosis and poor treatment outcomes [14, 15] . In breast cancer, peripheral T cell population changes were described in previous studies which include a decrease in cytotoxic T cell population, an increase in regulatory T cells, and an increase in senescent T cells [16, 17] . The presence of these features in peripheral T cells emphasizes the systemic effects of breast cancer cells on immune suppression. In a previous study, the presence ofsenescent T cells was not only associated with breast cancer patients, but also coincided with the presence of decreased TCRζ expre","cbCaikOm51MioxC0","https://ap.wps.com/l/cbCaikOm51MioxC0","pdf",500017,"English","# Abstract\n# Introduction\n# Materials and Methods\n# Results\n# Conclusion","[{\"question\":\"What is the main objective of the study?\",\"answer\":\"To determine whether cancer-associated non-exhausted senescent T cells are present in breast cancer patients and to assess how age progression affects their senescent phenotypes.\"},{\"question\":\"How were exhausted and senescent T cells distinguished?\",\"answer\":\"Exhausted T-cell lineages were excluded using the PD1 marker, while senescent phenotypes were determined using CD28- and further characterized with CD57 expression.\"},{\"question\":\"What did the results show about non-exhausted senescent T cells and age?\",\"answer\":\"Both senescent and non-exhausted senescent T cells increased in breast cancer patients; CD28-CD57+ cells rose with age progression, and dominant CD28-CD57- cells were attenuated after 52 years of age.\"}]","The Presence of Non-Exhausted Senescent T Cells in Breast Cancer Patients | PDF",1790190206,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3110b92500e753dc224d7a75a27e5d49.webp",983,1390,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f2e52be99b48b296ad1a9fcc437ebf3b.webp",982,1388,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/924f9e0b4dc952ca5123400c2b24da9d.webp",981,1387,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7227546acb4470759cb7fc56ad87d22e.webp",980,1385]